Skip to content

The effect of ciprofol combined with remifentanil on the postoperative recovery quality in patients undergoing cervical spine surgery

The effect of ciprofol combined with remifentanil on the postoperative recovery quality in patients undergoing cervical spine surgery

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098157
Enrollment
Unknown
Registered
2025-03-04
Start date
2025-03-05
Completion date
Unknown
Last updated
2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical spondylosis

Interventions

Propofol group:Propofol was used to induce 2 mg/kg, plasma targeted continuous intravenous infusion of remifentanil (3.0-5.0 ng/ml), and propofol was used to pump at a constant rate, with an initial d
Ciprofol group:0.4 mg/kg was induced with cyclopofol, plasma targeted continuous intravenous infusion of remifentanil (3.0-5.0 ng/ml), and cyclopofol was used to pump at a constant rate, with an initi

Sponsors

The First Affiliated Hospital of University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing anterior cervical decompression and fusion for the first time; 2. Age 18-70 years old; 3. ASA Grade I~III.; 4. BMI 15~28 kg/m^2 ; 5. Able to understand this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with cervical vertebra fracture caused by trauma; 2. the presence of a difficult airway in the preoperative assessment; 3. Patients who are allergic to anesthetic drugs such as cyclopofol and propofol; 4. Patients who have been taking sedative and anti-anxiety drugs for a long time; 5. Severe cardiovascular and cerebrovascular diseases or psychiatric diseases in the past; 6. Severe liver and kidney insufficiency; 7. Patient or family member refuses to participate in this study; 8. Patients participating in other clinical studies.

Design outcomes

Primary

MeasureTime frame
Postoperative recovery quality;

Secondary

MeasureTime frame
Mean arterial pressure;Heart rate;Intraoperative anaesthetic drug use;Extubation time;Duration of anaesthesia;Length of stay in the Postanesthesia care unit;Incidence of adverse events;Postoperative delirium;Postoperative sleep quality;Length of hospital stay;Postoperative complications;Duration of surgery;

Countries

China

Contacts

Public ContactJu Li

The First Affiliated Hospital of University of Science and Technology of China

huamuzi1999@163.com+86 139 5600 5465

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026